Comparison of the methylated BCAT1/IKZF1 blood test with a fecal immunochemical test for colorectal cancer screening.

被引：0
|
作者：
Symonds, E. L. [1 ,2 ]
Pedersen, S.
Baker, R.
Gopalsamy, G. [2 ]
Murray, D.
Cole, S. R. [1 ,2 ]
Lapointe, L.
Young, G. P. [2 ]
机构：
[1] Repatriat Gen Hosp, Bowel Hlth Serv, Daw Pk, SA, Australia
[2] Flinders Ctr Innovat Canc, Bedford Pk, SA, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2015年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1556
引用
收藏
页码：81 / 82
页数：2
相关论文
共 50 条
  • [31] Assessment of methylated BCAT1 and IKZF1 circulating tumor DNA as a potential diagnostic and prognostic biomarker in esophagogastic cancers
    Chan, Mei Mei
    Winter, Jean M.
    Pedersen, Susanne Kartin
    Roy, Amitesh Chandra
    Watson, David I.
    Hussey, Damian
    Young, Graeme P.
    Symonds, Erin L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [32] Evaluation of a panel of tumor-specific differentially-methylated DNA regions in IRF4, IKZF1 and BCAT1 for blood-based detection of colorectal cancer
    Young, Graeme P.
    Symonds, Erin L.
    Nielsen, Hans Jorgen
    Ferm, Linnea
    Christensen, Ib J.
    Dekker, Evelien
    van der Vlugt, Manon
    Mallant-Hent, Rosalie C.
    Boulter, Nicky
    Yu, Betty
    Chan, Michelle
    Tevz, Gregor
    LaPointe, Lawrence C.
    Pedersen, Susanne K.
    [J]. CLINICAL EPIGENETICS, 2021, 13 (01)
  • [33] BCAT1, IKZF1 and SEPT9: methylated DNA biomarkers for detection of pan-gastrointestinal adenocarcinomas
    Laven-Law, Geraldine
    Kichenadasse, Ganessan
    Young, Graeme P.
    Symonds, Erin L.
    Winter, Jean M.
    [J]. BIOMARKERS, 2024, 29 (04) : 194 - 204
  • [34] Evaluation of a panel of tumor-specific differentially-methylated DNA regions in IRF4, IKZF1 and BCAT1 for blood-based detection of colorectal cancer
    Graeme P. Young
    Erin L. Symonds
    Hans Jørgen Nielsen
    Linnea Ferm
    Ib J. Christensen
    Evelien Dekker
    Manon van der Vlugt
    Rosalie C. Mallant-Hent
    Nicky Boulter
    Betty Yu
    Michelle Chan
    Gregor Tevz
    Lawrence C. LaPointe
    Susanne K. Pedersen
    [J]. Clinical Epigenetics, 2021, 13
  • [35] Advantage of immunochemical fecal occult blood test in screening for colorectal cancer
    Launoy, G
    Berchi, C
    [J]. BULLETIN DU CANCER, 2005, 92 (10) : 885 - 890
  • [36] A comparison of fecal RNA test with immunochemical fecal occult blood test for detecting colorectal cancer and adenoma
    Kanaoka, Shigeru
    Takai, Tetsunari
    Yoshida, Ken-Ichi
    Hamaya, Yasushi
    Ikuma, Mutsuhiro
    Hishida, Akira
    [J]. GASTROENTEROLOGY, 2007, 132 (04) : A623 - A623
  • [37] Colorectal Cancer Screening: Fecal immunochemical Test or Sigmoidoscopy?
    Hofmann-Assmus, Marion
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2021, 59 (07): : 626 - 628
  • [38] A prospective cohort study in colorectal cancer assessing the relationship between post-surgery detection of methylated BCAT1 or IKZF1 ctDNA and risk for residual disease and survival.
    Murray, David
    Young, Graeme P.
    Pedersen, Susanne Kartin
    Rabbitt, Philippa
    Byrne, Susan E.
    Cornthwaite, Kathryn J.
    Roy, Amitesh
    Karapetis, Christos
    Symonds, Erin L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [39] Enhancing Colorectal Cancer Screening Specificity by Integrating Fecal MicroRNA Signature With Fecal Immunochemical Test and Fecal Occult Blood Test
    Noursina, Ali
    Safari, Farzad
    [J]. GASTROENTEROLOGY, 2024, 166 (02) : 358 - 358
  • [40] Comparing a fecal immunochemical test and circulating tumor DNA blood test for colorectal cancer screening adherence
    Laven-Law, Geraldine
    Symonds, Erin L.
    Winter, Jean M.
    Chen, Gang
    Flight, Ingrid H.
    Hughes-Barton, Donna
    Wilson, Carlene J.
    Young, Graeme P.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (07) : 1267 - 1276
12345